HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients.

AbstractBACKGROUND:
We previously reported that the activation of RANK and c-Met signaling components in both experimental mouse models and human prostate cancer (PC) specimens predicts bone metastatic potential and PC patient survival. This study addresses whether a population of metastasis-initiating cells (MICs) known to express a stronger RANKL, phosphorylated c-Met (p-c-Met), and neuropilin-1 (NRP1) signaling network than bystander or dormant cells (BDCs) can be detected in PC tissues from patients subjected to transurethral resection of the prostate (TURP) for urinary obstruction prior to the diagnosis of PC with or without prior hormonal manipulation, and whether the relative abundance of MICs over BDCs could predict castration-resistant progression and PC patient survival.
METHODS:
We employed a multiplexed quantum-dot labeling (mQDL) protocol to detect and quantify MICs and BDCs at the single cell level in TURP tissues obtained from 44 PC patients with documented overall survival and castration resistance status.
RESULTS:
PC tissues with a higher number of MICs and an activated RANK signaling network, including increased expression of RANKL, p-c-Met, and NRP1 compared to BDCs, were found to correlate with the development of castration resistance and overall survival.
CONCLUSIONS:
The assessment of PC cells with MIC and BDC phenotypes in primary PC tissues from hormone-naïve patients can predict the progression to castration resistance and the overall survival of PC patients.
AuthorsQinlong Li, Quanlin Li, Jill Nuccio, Chunyan Liu, Peng Duan, Ruoxiang Wang, Lawrence W Jones, Leland W K Chung, Haiyen E Zhau
JournalThe Prostate (Prostate) Vol. 75 Issue 12 Pg. 1312-21 (Sep 2015) ISSN: 1097-0045 [Electronic] United States
PMID25990623 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Copyright© 2015 Wiley Periodicals, Inc.
Chemical References
  • RANK Ligand
  • Proto-Oncogene Proteins c-met
  • Receptors, Atrial Natriuretic Factor
  • atrial natriuretic factor receptor A
Topics
  • Aged
  • Aged, 80 and over
  • Bone Neoplasms (mortality, secondary, surgery)
  • Disease Progression
  • Humans
  • Male
  • Middle Aged
  • Phosphorylation
  • Prognosis
  • Prostatic Neoplasms (mortality, pathology, surgery)
  • Prostatic Neoplasms, Castration-Resistant (diagnosis)
  • Proto-Oncogene Proteins c-met (metabolism)
  • Quantum Dots
  • RANK Ligand (metabolism)
  • Receptors, Atrial Natriuretic Factor (metabolism)
  • Signal Transduction
  • Survival Rate
  • Transurethral Resection of Prostate (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: